Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech. With two offices in Israel, Pitango currently manages several venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.
11 HaMenofim St. Building B, Herzliya 4672562 Israel
Aviv Barzilay
Value Creation Associate
Ori Barzilay
Senior Associate
Zeev Binman
Managing Partner and CFO
Yair Cassuto
Partner
Amir Faintuch
Venture Partner / Adviser
Jonathan Glazer
Venture Partner
Ittai Harel
Managing Partner
Maya Hawlasewicz
Senior Associate
Gad Huldai
Partner
Ayal Itzkovitz
Managing Partner
Rami Kalish
Managing Partner and Co-Founder
Hila Karah
Managing Partner
Aaron Mankovski
Managing Partner
Idit Muallem
Partner
Eyal Niv
Managing Partner
Joel Schoppig
Senior Principal
Liron Wand
Venture Partner
Past deals in Middle East
Quantum Source
Series A in 2024
Quantum Source is a company based in Rehovot, Israel, focused on developing a photonic quantum architecture for scalable and practical quantum computing. It aims to create systems that can operate with millions of qubits while significantly reducing complexity, footprint, power consumption, and cost compared to existing technologies. The company's innovative design utilizes chip-based photon-atom gates to facilitate the efficient exchange of quantum information between photonic and atomic qubits. By providing versatile building blocks for quantum systems, Quantum Source is positioned to enhance capabilities across various industries, including medicine, security, climate simulations, and finance, enabling solutions to complex computational challenges.
Incredo
Series C in 2023
Incredo, a global food-tech company founded in 2014, specializes in developing innovative technologies to enhance the sweetness of sugars without leaving an aftertaste. Based in Petach-Tikva, Israel, the company focuses on creating solutions that significantly reduce sugar consumption while maintaining the sensory qualities consumers expect from sweet foods. Incredo's proprietary technology allows for a sugar reduction made from real cane sugar, ensuring that taste, mouthfeel, and texture are preserved. By enabling healthier consumption of foods and snacks, Incredo provides consumers with the opportunity to enjoy their favorite products with substantial sugar reduction, ultimately promoting better dietary choices.
Magenta Medical
Venture Round in 2023
Magenta Medical Ltd. is a privately held company based in Kadima, Israel, founded in 2012. The company specializes in developing innovative medical devices aimed at treating acute decompensated heart failure. Its flagship product is a temporary venous catheter-based therapy that includes a self-expanding heart pump. This device targets critical issues related to acute heart failure, particularly renal venous congestion, which adversely affects both cardiac and renal function. By enabling physicians to more effectively manage fluid and salt removal in patients, Magenta Medical's technology enhances patient safety and supports kidney function, offering a promising solution for better management of heart failure.
Quantum Source
Seed Round in 2023
Quantum Source is a company based in Rehovot, Israel, focused on developing a photonic quantum architecture for scalable and practical quantum computing. It aims to create systems that can operate with millions of qubits while significantly reducing complexity, footprint, power consumption, and cost compared to existing technologies. The company's innovative design utilizes chip-based photon-atom gates to facilitate the efficient exchange of quantum information between photonic and atomic qubits. By providing versatile building blocks for quantum systems, Quantum Source is positioned to enhance capabilities across various industries, including medicine, security, climate simulations, and finance, enabling solutions to complex computational challenges.
AI21 Labs
Series B in 2022
AI21 Labs, founded in 2017 and based in Tel Aviv-Yafo, Israel, specializes in developing generative artificial intelligence and large language models. The company creates tools designed to enhance the understanding and generation of natural language, effectively transforming how users read and write. Its AI-driven writing companion captures real intelligence, rephrasing text to convey precise meanings while providing summaries that aid in comprehension. These innovations empower users to analyze and visualize complex information more efficiently, facilitating a deeper understanding of abstract knowledge structures. Through the application of deep learning and computer vision algorithms, AI21 Labs aims to significantly improve the efficiency of reading and writing processes.
Quantum Source
Seed Round in 2022
Quantum Source is a company based in Rehovot, Israel, focused on developing a photonic quantum architecture for scalable and practical quantum computing. It aims to create systems that can operate with millions of qubits while significantly reducing complexity, footprint, power consumption, and cost compared to existing technologies. The company's innovative design utilizes chip-based photon-atom gates to facilitate the efficient exchange of quantum information between photonic and atomic qubits. By providing versatile building blocks for quantum systems, Quantum Source is positioned to enhance capabilities across various industries, including medicine, security, climate simulations, and finance, enabling solutions to complex computational challenges.
Indoor Robotics
Series A in 2022
Indoor Robotics Ltd, founded in 2018 and based in Ramat Gan, Israel, specializes in the design and development of Tando, an AI-powered patrol drone tailored for indoor security and inspection tasks. Tando employs independent AI-based navigation and a patented ceiling docking system, providing real-time coverage and utilizing predictive analysis to reduce false alarms. The drone autonomously collects and analyzes data, promoting consistent quality and enhancing safety. This innovative solution combines robotics with advanced AI capabilities, offering a cost-effective and efficient approach to intelligent indoor monitoring. By collaborating with leaders in the security and smart building sectors, Indoor Robotics aims to transform the landscape of indoor surveillance and inspection through improved area coverage and response times.
Nexite
Series C in 2022
Nexite Ltd, founded in 2017 and based in Tel Aviv, Israel, has developed a platform that enhances engagement with physical items for retailers and brands. The company offers a unique solution through its miniature NanoBT tags, which are battery-free, cost-effective, and can be embedded into products. This technology enables item tracking, inventory transparency, and business intelligence from manufacturing to the consumer's home. The platform provides real-time insights into customer behavior and item performance, assisting businesses in stock management, loss prevention, and optimizing in-store sales. By delivering actionable data on location and availability, Nexite's solutions facilitate improved customer experiences and support the development of new revenue streams for retailers.
Frontegg
Series A in 2021
Frontegg develops a user management platform aimed at enhancing software as a service (SaaS) solutions. The platform enables SaaS companies to integrate fully managed, scalable features with minimal coding, facilitating seamless implementation into existing applications. Frontegg supports modern application needs by providing a comprehensive suite of functionalities, including authentication flows, multi-tenancy, fine-grained authorization, API-token management, and single-sign-on (SSO). Its user interfaces serve as customer-facing management tools, while the backend is strengthened by a rich set of software development kits (SDKs) compatible with various programming languages and frameworks. Founded in 1982 and headquartered in Tel-Aviv, Israel, Frontegg positions itself as a key enabler for product-led growth in the SaaS industry.
Swimm
Series A in 2021
Swimm is a knowledge management platform designed specifically for software developers, established in 2019 and headquartered in Tel Aviv-Yafo, Israel. The company focuses on enhancing onboarding and training by providing tools that facilitate understanding and collaboration within codebases. Unlike traditional documentation solutions that can be outdated or hard to find, Swimm enables developers to create internal documentation that is easily accessible within their integrated development environments (IDEs). Its platform features auto-sync technology that ensures documentation remains current with code changes, along with tools for quick searching, highlighting code sections, and adding comments for clarity. By prioritizing knowledge sharing, Swimm aims to streamline developer processes, improve team standardization, and reduce the time spent on information sharing.
Lumigo
Series A in 2021
Lumigo Ltd. operates a platform designed for monitoring, troubleshooting, and optimizing serverless applications. Founded in 2018 and based in Tel Aviv, Israel, the platform leverages data analysis to understand the normal behavior of serverless applications, providing live visual maps and insights for developers. This functionality enables operations teams to trace requests not only through the serverless infrastructure but also across related services, such as databases and storage. By implementing distributed tracing, Lumigo offers end-to-end stack traces that include full HTTP payload data, allowing organizations to quickly address critical production issues without the need for extensive logging. The platform also enhances visibility and traceability, helping enterprises prevent service disruptions through actionable alerts based on user behavior analytics.
StreamElements
Series B in 2021
StreamElements is a content creation platform that supports live content creators in monetization, audience management, and community growth. Founded in 2016 and based in Tel Aviv, Israel, the platform offers a suite of tools including cloud-based overlays, alerts, chatbots, loyalty programs, and brand-safe moderation. These features enable creators to engage their audiences effectively while providing them with opportunities for revenue generation through donations, unblockable ads, and a unique currency system for purchasing in-stream items. StreamElements serves a diverse range of platforms, including Twitch, YouTube, Twitter, and TikTok, and facilitates connections between creators and brands through performance marketing campaigns. Its robust backend tools, such as chat analytics and subscriber management, enhance the live streaming experience, ultimately helping creators grow their channels and increase their revenue.
Tailor Brands
Series C in 2021
Tailor Brands, LTD. is an online platform that facilitates the design of brand logos, business cards, and letterheads, enabling users to create a distinct brand identity. Founded in 2014 and headquartered in Tel Aviv, Israel, the company offers a comprehensive suite of tools that simplifies the process of starting and managing a business. Tailor Brands provides services ranging from LLC formation and obtaining necessary business permits to website development and personalized branding guidance. The platform aims to connect all essential resources in a streamlined experience, allowing entrepreneurs to efficiently build and grow their businesses while crafting a unique online presence.
Perception Point
Series B in 2021
Perception Point LTD is a cybersecurity technology company based in Tel Aviv, Israel, specializing in advanced threat detection and response. The company offers a cloud-based platform that safeguards organizations from cyber threats by monitoring and preventing attacks across various enterprise collaboration channels, including email, web, and cloud services. Its innovative approach allows direct access to a computer system's CPU, enabling the detection and prevention of threats before they can be exploited. Perception Point serves a diverse range of industries, including finance, healthcare, and education, providing comprehensive solutions to protect sensitive data and networks from phishing and other malicious activities.
Swimm
Seed Round in 2021
Swimm is a knowledge management platform designed specifically for software developers, established in 2019 and headquartered in Tel Aviv-Yafo, Israel. The company focuses on enhancing onboarding and training by providing tools that facilitate understanding and collaboration within codebases. Unlike traditional documentation solutions that can be outdated or hard to find, Swimm enables developers to create internal documentation that is easily accessible within their integrated development environments (IDEs). Its platform features auto-sync technology that ensures documentation remains current with code changes, along with tools for quick searching, highlighting code sections, and adding comments for clarity. By prioritizing knowledge sharing, Swimm aims to streamline developer processes, improve team standardization, and reduce the time spent on information sharing.
BrainsGate
Series F in 2020
BrainsGate, Ltd. is a medical device company based in Caesarea, Israel, specializing in therapies for patients with central nervous system diseases. The company has developed a technology platform that utilizes electrical stimulation of the spheno-palatine ganglion (SPG) to enhance cerebral blood flow. Currently, BrainsGate is focused on treating acute ischemic stroke through its innovative ischemic stroke system, which involves a miniature electrode implanted in the roof of the mouth during a minimally invasive procedure. This method is performed under local anesthesia and is comparable to standard dental treatments. The company has conducted several clinical trials, including a pivotal trial with 300 patients that validated the safety and efficacy of its treatment. BrainsGate is also engaged in a multi-national, randomized study known as ImpACT-24b, aimed at further assessing the effectiveness of its approach within a critical 24-hour window following a stroke.
Frontegg
Seed Round in 2020
Frontegg develops a user management platform aimed at enhancing software as a service (SaaS) solutions. The platform enables SaaS companies to integrate fully managed, scalable features with minimal coding, facilitating seamless implementation into existing applications. Frontegg supports modern application needs by providing a comprehensive suite of functionalities, including authentication flows, multi-tenancy, fine-grained authorization, API-token management, and single-sign-on (SSO). Its user interfaces serve as customer-facing management tools, while the backend is strengthened by a rich set of software development kits (SDKs) compatible with various programming languages and frameworks. Founded in 1982 and headquartered in Tel-Aviv, Israel, Frontegg positions itself as a key enabler for product-led growth in the SaaS industry.
keepMED
Series C in 2020
keepMED Ltd. is a company focused on developing and commercializing innovative solutions for the treatment of Obstructive Sleep Apnea (OSA), a condition marked by repeated episodes of upper airway obstruction during sleep. The company's primary product, keePAP, is a lightweight and unobtrusive wearable device that includes a nasal interface and a miniature battery-operated control unit. Founded in 2012 and based in Rishon Le Zion, Israel, keepMED aims to provide effective treatment options for individuals suffering from OSA.
Convizit
Seed Round in 2020
Convizit Ltd., based in Tel Aviv, Israel, specializes in web analytics software that utilizes AI technology to automatically capture and analyze user interactions on websites and SaaS applications. The platform collects detailed behavioral data with minimal effort required from users, eliminating the need for manual coding or tagging of events. By enriching this data with relevant properties, Convizit delivers a comprehensive stream of user behavior information directly to various analytics, marketing, and customer data platforms. This approach allows businesses to access reliable behavioral insights quickly, without the traditional challenges of data collection, which can be time-consuming and prone to inaccuracies. Convizit aims to transform the way organizations leverage behavioral data, enabling them to enhance analytics, business intelligence, and personalization efforts effortlessly. The company is actively expanding its team of developers and data scientists to further innovate within the digital analytics space.
CLEW Medical
Series B in 2020
CLEW Medical Ltd. is a company that develops an analytics platform designed for healthcare providers and administrators to predict life-threatening complications in intensive care units (ICUs). Founded in 2014 and based in Netanya, Israel, CLEW Medical utilizes ICU data to deliver predictive clinical analytics that assist hospital management and medical personnel in monitoring patient conditions. The platform generates real-time alerts regarding patient deterioration, facilitating early intervention and enhancing clinical outcomes. By employing advanced predictive models and high-dimensional analytics, CLEW's solution can effectively manage large patient populations while addressing individual treatment needs. The team at CLEW Medical brings extensive experience in supporting healthcare institutions in achieving their objectives through innovative research and technology.
Riskified
Series E in 2019
Riskified Ltd. is a fraud prevention platform designed for online merchants, founded in 2013 and based in Tel Aviv, Israel. The platform integrates with various e-commerce systems to provide decisive approval or decline recommendations for transactions, enabling merchants to foster trusted relationships with their customers. Using machine learning and insights from a global network of merchants, Riskified helps identify the legitimacy of online interactions, thereby mitigating risk and uncertainty. The platform not only drives higher sales but also reduces fraud and operational costs for its clients, enhancing consumer experiences. Riskified serves a diverse clientele across multiple sectors, including fashion, electronics, and travel, with notable partnerships including brands such as Wayfair, SHEIN, and Macy's. The company derives a significant portion of its revenue from operations in Israel.
Neura
Series B in 2019
Neura, Inc. specializes in the development of software development kits and artificial intelligence tools designed to enhance the performance of mobile applications and Internet of Things (IoT) devices. The company's platform establishes logical connections between users' devices, their communities, and various online resources, utilizing intelligence to anticipate user needs and provide relevant suggestions. Neura's offerings cater to a diverse range of sectors, including health and wellness, retail and e-commerce, food delivery, media and entertainment, transportation, travel, finance, and gaming. Founded in 2012 and headquartered in Palo Alto, California, Neura also maintains a research and development center in Herzliya, Israel.
Convizit
Seed Round in 2019
Convizit Ltd., based in Tel Aviv, Israel, specializes in web analytics software that utilizes AI technology to automatically capture and analyze user interactions on websites and SaaS applications. The platform collects detailed behavioral data with minimal effort required from users, eliminating the need for manual coding or tagging of events. By enriching this data with relevant properties, Convizit delivers a comprehensive stream of user behavior information directly to various analytics, marketing, and customer data platforms. This approach allows businesses to access reliable behavioral insights quickly, without the traditional challenges of data collection, which can be time-consuming and prone to inaccuracies. Convizit aims to transform the way organizations leverage behavioral data, enabling them to enhance analytics, business intelligence, and personalization efforts effortlessly. The company is actively expanding its team of developers and data scientists to further innovate within the digital analytics space.
Magenta Medical
Venture Round in 2019
Magenta Medical Ltd. is a privately held company based in Kadima, Israel, founded in 2012. The company specializes in developing innovative medical devices aimed at treating acute decompensated heart failure. Its flagship product is a temporary venous catheter-based therapy that includes a self-expanding heart pump. This device targets critical issues related to acute heart failure, particularly renal venous congestion, which adversely affects both cardiac and renal function. By enabling physicians to more effectively manage fluid and salt removal in patients, Magenta Medical's technology enhances patient safety and supports kidney function, offering a promising solution for better management of heart failure.
StreamElements
Series A in 2019
StreamElements is a content creation platform that supports live content creators in monetization, audience management, and community growth. Founded in 2016 and based in Tel Aviv, Israel, the platform offers a suite of tools including cloud-based overlays, alerts, chatbots, loyalty programs, and brand-safe moderation. These features enable creators to engage their audiences effectively while providing them with opportunities for revenue generation through donations, unblockable ads, and a unique currency system for purchasing in-stream items. StreamElements serves a diverse range of platforms, including Twitch, YouTube, Twitter, and TikTok, and facilitates connections between creators and brands through performance marketing campaigns. Its robust backend tools, such as chat analytics and subscriber management, enhance the live streaming experience, ultimately helping creators grow their channels and increase their revenue.
Lumigo
Seed Round in 2019
Lumigo Ltd. operates a platform designed for monitoring, troubleshooting, and optimizing serverless applications. Founded in 2018 and based in Tel Aviv, Israel, the platform leverages data analysis to understand the normal behavior of serverless applications, providing live visual maps and insights for developers. This functionality enables operations teams to trace requests not only through the serverless infrastructure but also across related services, such as databases and storage. By implementing distributed tracing, Lumigo offers end-to-end stack traces that include full HTTP payload data, allowing organizations to quickly address critical production issues without the need for extensive logging. The platform also enhances visibility and traceability, helping enterprises prevent service disruptions through actionable alerts based on user behavior analytics.
AI21 Labs
Seed Round in 2019
AI21 Labs, founded in 2017 and based in Tel Aviv-Yafo, Israel, specializes in developing generative artificial intelligence and large language models. The company creates tools designed to enhance the understanding and generation of natural language, effectively transforming how users read and write. Its AI-driven writing companion captures real intelligence, rephrasing text to convey precise meanings while providing summaries that aid in comprehension. These innovations empower users to analyze and visualize complex information more efficiently, facilitating a deeper understanding of abstract knowledge structures. Through the application of deep learning and computer vision algorithms, AI21 Labs aims to significantly improve the efficiency of reading and writing processes.
Indoor Robotics
Seed Round in 2019
Indoor Robotics Ltd, founded in 2018 and based in Ramat Gan, Israel, specializes in the design and development of Tando, an AI-powered patrol drone tailored for indoor security and inspection tasks. Tando employs independent AI-based navigation and a patented ceiling docking system, providing real-time coverage and utilizing predictive analysis to reduce false alarms. The drone autonomously collects and analyzes data, promoting consistent quality and enhancing safety. This innovative solution combines robotics with advanced AI capabilities, offering a cost-effective and efficient approach to intelligent indoor monitoring. By collaborating with leaders in the security and smart building sectors, Indoor Robotics aims to transform the landscape of indoor surveillance and inspection through improved area coverage and response times.
Nexite
Series A in 2018
Nexite Ltd, founded in 2017 and based in Tel Aviv, Israel, has developed a platform that enhances engagement with physical items for retailers and brands. The company offers a unique solution through its miniature NanoBT tags, which are battery-free, cost-effective, and can be embedded into products. This technology enables item tracking, inventory transparency, and business intelligence from manufacturing to the consumer's home. The platform provides real-time insights into customer behavior and item performance, assisting businesses in stock management, loss prevention, and optimizing in-store sales. By delivering actionable data on location and availability, Nexite's solutions facilitate improved customer experiences and support the development of new revenue streams for retailers.
Tailor Brands
Series B in 2018
Tailor Brands, LTD. is an online platform that facilitates the design of brand logos, business cards, and letterheads, enabling users to create a distinct brand identity. Founded in 2014 and headquartered in Tel Aviv, Israel, the company offers a comprehensive suite of tools that simplifies the process of starting and managing a business. Tailor Brands provides services ranging from LLC formation and obtaining necessary business permits to website development and personalized branding guidance. The platform aims to connect all essential resources in a streamlined experience, allowing entrepreneurs to efficiently build and grow their businesses while crafting a unique online presence.
Sckipio
Series D in 2018
Sckipio Technologies is a semiconductor company based in Ramat Gan, Israel, that specializes in Gfast technologies aimed at providing ultra-broadband access. Founded in 2012, Sckipio focuses on delivering fiber-like broadband capabilities over existing infrastructure, specifically through next-generation G.fast-based Fiber-to-the-Distribution Point (FTTdp) architectures. The company is notable for being the first to launch Gfast modems and has made significant contributions to the Gfast standard, accounting for over 20% of its development. Sckipio's award-winning technology enables faster internet access over distances of up to 300 meters, facilitating improved connectivity for businesses and users alike.
Perception Point
Series A in 2018
Perception Point LTD is a cybersecurity technology company based in Tel Aviv, Israel, specializing in advanced threat detection and response. The company offers a cloud-based platform that safeguards organizations from cyber threats by monitoring and preventing attacks across various enterprise collaboration channels, including email, web, and cloud services. Its innovative approach allows direct access to a computer system's CPU, enabling the detection and prevention of threats before they can be exploited. Perception Point serves a diverse range of industries, including finance, healthcare, and education, providing comprehensive solutions to protect sensitive data and networks from phishing and other malicious activities.
Magenta Medical
Series B in 2017
Magenta Medical Ltd. is a privately held company based in Kadima, Israel, founded in 2012. The company specializes in developing innovative medical devices aimed at treating acute decompensated heart failure. Its flagship product is a temporary venous catheter-based therapy that includes a self-expanding heart pump. This device targets critical issues related to acute heart failure, particularly renal venous congestion, which adversely affects both cardiac and renal function. By enabling physicians to more effectively manage fluid and salt removal in patients, Magenta Medical's technology enhances patient safety and supports kidney function, offering a promising solution for better management of heart failure.
Incredo
Series A in 2017
Incredo, a global food-tech company founded in 2014, specializes in developing innovative technologies to enhance the sweetness of sugars without leaving an aftertaste. Based in Petach-Tikva, Israel, the company focuses on creating solutions that significantly reduce sugar consumption while maintaining the sensory qualities consumers expect from sweet foods. Incredo's proprietary technology allows for a sugar reduction made from real cane sugar, ensuring that taste, mouthfeel, and texture are preserved. By enabling healthier consumption of foods and snacks, Incredo provides consumers with the opportunity to enjoy their favorite products with substantial sugar reduction, ultimately promoting better dietary choices.
Riskified
Series C in 2017
Riskified Ltd. is a fraud prevention platform designed for online merchants, founded in 2013 and based in Tel Aviv, Israel. The platform integrates with various e-commerce systems to provide decisive approval or decline recommendations for transactions, enabling merchants to foster trusted relationships with their customers. Using machine learning and insights from a global network of merchants, Riskified helps identify the legitimacy of online interactions, thereby mitigating risk and uncertainty. The platform not only drives higher sales but also reduces fraud and operational costs for its clients, enhancing consumer experiences. Riskified serves a diverse clientele across multiple sectors, including fashion, electronics, and travel, with notable partnerships including brands such as Wayfair, SHEIN, and Macy's. The company derives a significant portion of its revenue from operations in Israel.
CLEW Medical
Series A in 2017
CLEW Medical Ltd. is a company that develops an analytics platform designed for healthcare providers and administrators to predict life-threatening complications in intensive care units (ICUs). Founded in 2014 and based in Netanya, Israel, CLEW Medical utilizes ICU data to deliver predictive clinical analytics that assist hospital management and medical personnel in monitoring patient conditions. The platform generates real-time alerts regarding patient deterioration, facilitating early intervention and enhancing clinical outcomes. By employing advanced predictive models and high-dimensional analytics, CLEW's solution can effectively manage large patient populations while addressing individual treatment needs. The team at CLEW Medical brings extensive experience in supporting healthcare institutions in achieving their objectives through innovative research and technology.
Sckipio
Series C in 2016
Sckipio Technologies is a semiconductor company based in Ramat Gan, Israel, that specializes in Gfast technologies aimed at providing ultra-broadband access. Founded in 2012, Sckipio focuses on delivering fiber-like broadband capabilities over existing infrastructure, specifically through next-generation G.fast-based Fiber-to-the-Distribution Point (FTTdp) architectures. The company is notable for being the first to launch Gfast modems and has made significant contributions to the Gfast standard, accounting for over 20% of its development. Sckipio's award-winning technology enables faster internet access over distances of up to 300 meters, facilitating improved connectivity for businesses and users alike.
Skycure
Series B in 2016
Skycure Ltd. specializes in enterprise mobile threat defense solutions designed to protect against a variety of mobile cyber threats, including malware, network-based attacks, and device vulnerabilities. Founded in 2012 and based in Tel Aviv, Israel, the company offers a suite of products that integrates with platforms such as AirWatch, MobileIron, Citrix, and Microsoft Exchange and Office 365. These solutions facilitate real-time detection and remediation of potential threats, thereby helping organizations secure both corporate-owned and bring-your-own-device (BYO) environments. Skycure utilizes a dual protection mechanism that combines client-side modules on devices with server-side analysis, leveraging crowd intelligence and machine learning to enhance its predictive capabilities. The company's research team is recognized for its contributions to mobile security, ensuring that Skycure remains equipped to address emerging threats. As of 2017, Skycure operates as a subsidiary of Symantec Corporation.
Neura
Series A in 2016
Neura, Inc. specializes in the development of software development kits and artificial intelligence tools designed to enhance the performance of mobile applications and Internet of Things (IoT) devices. The company's platform establishes logical connections between users' devices, their communities, and various online resources, utilizing intelligence to anticipate user needs and provide relevant suggestions. Neura's offerings cater to a diverse range of sectors, including health and wellness, retail and e-commerce, food delivery, media and entertainment, transportation, travel, finance, and gaming. Founded in 2012 and headquartered in Palo Alto, California, Neura also maintains a research and development center in Herzliya, Israel.
OptimalPlus
Series C in 2015
OptimalPlus is the global leader in lifecycle analytics solutions for the automotive, semiconductor, and electronics industries, serving tier-1 suppliers and OEMs. Analyzing data from over 100 billion devices annually, OptimalPlus enables enhancements in key manufacturing metrics such as yield and efficiency, improves product quality and reliability, and provides full supply chain visibility. Seamlessly integrated with other already existing tools, the OptimalPlus Open Platform combines machine-learning with a global data infrastructure to provide real-time product analytics and to extract insights from data across the entire supply chain. OptimalPlus has offices in Asia, Europe, the United States, and Israel. For more information, visit http://www.optimalplus.com/
keepMED
Series B in 2015
keepMED Ltd. is a company focused on developing and commercializing innovative solutions for the treatment of Obstructive Sleep Apnea (OSA), a condition marked by repeated episodes of upper airway obstruction during sleep. The company's primary product, keePAP, is a lightweight and unobtrusive wearable device that includes a nasal interface and a miniature battery-operated control unit. Founded in 2012 and based in Rishon Le Zion, Israel, keepMED aims to provide effective treatment options for individuals suffering from OSA.
Sckipio
Series B in 2014
Sckipio Technologies is a semiconductor company based in Ramat Gan, Israel, that specializes in Gfast technologies aimed at providing ultra-broadband access. Founded in 2012, Sckipio focuses on delivering fiber-like broadband capabilities over existing infrastructure, specifically through next-generation G.fast-based Fiber-to-the-Distribution Point (FTTdp) architectures. The company is notable for being the first to launch Gfast modems and has made significant contributions to the Gfast standard, accounting for over 20% of its development. Sckipio's award-winning technology enables faster internet access over distances of up to 300 meters, facilitating improved connectivity for businesses and users alike.
Neura
Venture Round in 2014
Neura, Inc. specializes in the development of software development kits and artificial intelligence tools designed to enhance the performance of mobile applications and Internet of Things (IoT) devices. The company's platform establishes logical connections between users' devices, their communities, and various online resources, utilizing intelligence to anticipate user needs and provide relevant suggestions. Neura's offerings cater to a diverse range of sectors, including health and wellness, retail and e-commerce, food delivery, media and entertainment, transportation, travel, finance, and gaming. Founded in 2012 and headquartered in Palo Alto, California, Neura also maintains a research and development center in Herzliya, Israel.
Revizer
Venture Round in 2013
Revizer Technologies Ltd. specializes in creating revenue generating opportunities for software developers. It offers Revizer, an all-in-one monetization solution for application developers that can be implemented via a unique code providing users with targeted and optimized offers. The company offers developers an opportunity to incorporate revenue-generating elements to their software that enhances their bottom line without disrupting the user experience. The company’s advertising network provides exposure to target audience and enhances brand awareness in news, entertainment, lifestyle, sports, and social media outlets. Its technology allows developers to create a revenue model that is tailor-fit to user profiles, as well as financial and business goals. The company was founded in 2009 and is based in Tel Aviv, Israel.
Magenta Medical
Seed Round in 2012
Magenta Medical Ltd. is a privately held company based in Kadima, Israel, founded in 2012. The company specializes in developing innovative medical devices aimed at treating acute decompensated heart failure. Its flagship product is a temporary venous catheter-based therapy that includes a self-expanding heart pump. This device targets critical issues related to acute heart failure, particularly renal venous congestion, which adversely affects both cardiac and renal function. By enabling physicians to more effectively manage fluid and salt removal in patients, Magenta Medical's technology enhances patient safety and supports kidney function, offering a promising solution for better management of heart failure.
Skycure
Seed Round in 2012
Skycure Ltd. specializes in enterprise mobile threat defense solutions designed to protect against a variety of mobile cyber threats, including malware, network-based attacks, and device vulnerabilities. Founded in 2012 and based in Tel Aviv, Israel, the company offers a suite of products that integrates with platforms such as AirWatch, MobileIron, Citrix, and Microsoft Exchange and Office 365. These solutions facilitate real-time detection and remediation of potential threats, thereby helping organizations secure both corporate-owned and bring-your-own-device (BYO) environments. Skycure utilizes a dual protection mechanism that combines client-side modules on devices with server-side analysis, leveraging crowd intelligence and machine learning to enhance its predictive capabilities. The company's research team is recognized for its contributions to mobile security, ensuring that Skycure remains equipped to address emerging threats. As of 2017, Skycure operates as a subsidiary of Symantec Corporation.
BrainsGate
Series C in 2008
BrainsGate, Ltd. is a medical device company based in Caesarea, Israel, specializing in therapies for patients with central nervous system diseases. The company has developed a technology platform that utilizes electrical stimulation of the spheno-palatine ganglion (SPG) to enhance cerebral blood flow. Currently, BrainsGate is focused on treating acute ischemic stroke through its innovative ischemic stroke system, which involves a miniature electrode implanted in the roof of the mouth during a minimally invasive procedure. This method is performed under local anesthesia and is comparable to standard dental treatments. The company has conducted several clinical trials, including a pivotal trial with 300 patients that validated the safety and efficacy of its treatment. BrainsGate is also engaged in a multi-national, randomized study known as ImpACT-24b, aimed at further assessing the effectiveness of its approach within a critical 24-hour window following a stroke.
Iamba
Venture Round in 2008
Iamba Networks specializes in gigabit passive optical network solutions tailored for telecommunications equipment manufacturers and original device manufacturers. Founded in 2000 and headquartered in Cupertino, California, the company also has a research and development center in Israel. Iamba Networks focuses on developing fiber-to-the-premises (FTTP) solutions, enhancing connectivity and broadband capabilities for its clients. As of late 2008, Iamba operates as a subsidiary of Marvell Technology Group Ltd.
Pythagoras Solar
Series A in 2008
Pythagoras Solar is focused on dramatically changing the economics of photovoltaic technology through innovation that changes some of the basic technical principles behind the discipline. To accomplish its goals, the company is working to combine software models, optic design, semiconductor processes, materials science, and mass manufacturing techniques to build highly durable, cost effective solar energy products. Pythagoras Solar was founded in December 2006 by Gonen Fink, Dr. Itay Baruchi, and Precede Technologies. It is based in Hakfar Hayarok, Israel with offices in San Mateo, CA.
OptimalPlus
Series B in 2007
OptimalPlus is the global leader in lifecycle analytics solutions for the automotive, semiconductor, and electronics industries, serving tier-1 suppliers and OEMs. Analyzing data from over 100 billion devices annually, OptimalPlus enables enhancements in key manufacturing metrics such as yield and efficiency, improves product quality and reliability, and provides full supply chain visibility. Seamlessly integrated with other already existing tools, the OptimalPlus Open Platform combines machine-learning with a global data infrastructure to provide real-time product analytics and to extract insights from data across the entire supply chain. OptimalPlus has offices in Asia, Europe, the United States, and Israel. For more information, visit http://www.optimalplus.com/
Anobit Technologies
Series A in 2007
Anobit Technologies is a fabless semiconductor company that specializes in developing solutions for the Flash memory market. Founded in 2006 and based in Pituach, Israel, the company focuses on optimizing Flash memory devices for storage applications. Anobit's technology enhances the performance of NAND flash memory chips, which are integral to various consumer electronics, including iPhones, iPads, and iPods. By improving speed, endurance, and overall performance, Anobit's innovations enable clients to enhance their flash storage systems while reducing costs. In December 2011, Anobit Technologies was acquired by Apple, further integrating its advancements into Apple's product ecosystem.
Iamba
Series B in 2006
Iamba Networks specializes in gigabit passive optical network solutions tailored for telecommunications equipment manufacturers and original device manufacturers. Founded in 2000 and headquartered in Cupertino, California, the company also has a research and development center in Israel. Iamba Networks focuses on developing fiber-to-the-premises (FTTP) solutions, enhancing connectivity and broadband capabilities for its clients. As of late 2008, Iamba operates as a subsidiary of Marvell Technology Group Ltd.
Neocrafts
Series A in 2006
Neocrafts designed and developed the first digital guitar for the music industry. The company was founded in 2004 and was based in Israel.
CogniTens
Series E in 2005
CogniTens, Ltd. specializes in advanced three-dimensional optical measurement solutions for the automotive and manufacturing industries. The company offers a range of products, including Optigo, a portable platform for dimensional measurement, and OptiCell, an automated system for off-line recurring measurements on the production floor. Additionally, CogniTens provides software solutions such as CoreView Plan for developing measurement programs, CoreView Pro for analyzing and reporting measurement data, and CoreView Lite for viewing results. Their offerings facilitate industrial engineering activities, including tooling, part production, assembly, quality assurance, and process control. Founded in 1995 and headquartered in Ramat Hasharon, Israel, CogniTens serves automotive original equipment manufacturers, tier-one suppliers, tool and die companies, and other engineering organizations through a network of distributors.
BioLineRx
Venture Round in 2005
BioLineRx Ltd. is a clinical-stage biopharmaceutical development company based in Modi’in, Israel, specializing in oncology. The company’s pipeline includes two primary therapeutic candidates: BL-8040, a novel peptide designed for treating solid tumors, hematological malignancies, and facilitating stem cell mobilization, and AGI-134, an immuno-oncology agent targeted at solid tumors. Additionally, BioLineRx offers BL-5010, a proprietary pen-like applicator intended for the non-surgical removal of skin lesions. The company actively collaborates with prominent organizations such as MSD, MD Anderson Cancer Center, and Genentech to explore innovative treatment combinations and advance its clinical studies. Established in 2003, BioLineRx focuses on addressing unmet medical needs in the pharmaceutical sector.
BrainsGate
Venture Round in 2005
BrainsGate, Ltd. is a medical device company based in Caesarea, Israel, specializing in therapies for patients with central nervous system diseases. The company has developed a technology platform that utilizes electrical stimulation of the spheno-palatine ganglion (SPG) to enhance cerebral blood flow. Currently, BrainsGate is focused on treating acute ischemic stroke through its innovative ischemic stroke system, which involves a miniature electrode implanted in the roof of the mouth during a minimally invasive procedure. This method is performed under local anesthesia and is comparable to standard dental treatments. The company has conducted several clinical trials, including a pivotal trial with 300 patients that validated the safety and efficacy of its treatment. BrainsGate is also engaged in a multi-national, randomized study known as ImpACT-24b, aimed at further assessing the effectiveness of its approach within a critical 24-hour window following a stroke.
OptimalPlus
Series A in 2005
OptimalPlus is the global leader in lifecycle analytics solutions for the automotive, semiconductor, and electronics industries, serving tier-1 suppliers and OEMs. Analyzing data from over 100 billion devices annually, OptimalPlus enables enhancements in key manufacturing metrics such as yield and efficiency, improves product quality and reliability, and provides full supply chain visibility. Seamlessly integrated with other already existing tools, the OptimalPlus Open Platform combines machine-learning with a global data infrastructure to provide real-time product analytics and to extract insights from data across the entire supply chain. OptimalPlus has offices in Asia, Europe, the United States, and Israel. For more information, visit http://www.optimalplus.com/
CogniTens
Series D in 2003
CogniTens, Ltd. specializes in advanced three-dimensional optical measurement solutions for the automotive and manufacturing industries. The company offers a range of products, including Optigo, a portable platform for dimensional measurement, and OptiCell, an automated system for off-line recurring measurements on the production floor. Additionally, CogniTens provides software solutions such as CoreView Plan for developing measurement programs, CoreView Pro for analyzing and reporting measurement data, and CoreView Lite for viewing results. Their offerings facilitate industrial engineering activities, including tooling, part production, assembly, quality assurance, and process control. Founded in 1995 and headquartered in Ramat Hasharon, Israel, CogniTens serves automotive original equipment manufacturers, tier-one suppliers, tool and die companies, and other engineering organizations through a network of distributors.
BrainsGate
Seed Round in 2002
BrainsGate, Ltd. is a medical device company based in Caesarea, Israel, specializing in therapies for patients with central nervous system diseases. The company has developed a technology platform that utilizes electrical stimulation of the spheno-palatine ganglion (SPG) to enhance cerebral blood flow. Currently, BrainsGate is focused on treating acute ischemic stroke through its innovative ischemic stroke system, which involves a miniature electrode implanted in the roof of the mouth during a minimally invasive procedure. This method is performed under local anesthesia and is comparable to standard dental treatments. The company has conducted several clinical trials, including a pivotal trial with 300 patients that validated the safety and efficacy of its treatment. BrainsGate is also engaged in a multi-national, randomized study known as ImpACT-24b, aimed at further assessing the effectiveness of its approach within a critical 24-hour window following a stroke.
Mysticom
Venture Round in 2001
Mysticom is a company based in Netanya, Israel, that specializes in developing integrated circuit (IC) solutions for enterprise, data center, and storage markets. Founded in 1997, it focuses on designing network ICs, including digital signal processing and mixed-signal VLSI solutions tailored for high-speed communication systems. Mysticom provides design services in areas such as communications system design and VLSI integration. Additionally, the company offers PC network interface cards and LAN on motherboard solutions, alongside deploying gigabit Ethernet switch equipment to enhance network performance.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.